Population Characteristics
| Characteristic | All patients (n = 77) | 90Y resin group (n = 41) | 90Y glass group (n = 36) | P |
| Age (y) | 68 (60–74) | 68 (58–72) | 71 (62–75) | 0.05 |
| Female | 10 (12.9) | 4 (9.8) | 6 (16.7) | 0.37 |
| Comorbidities | ||||
| Hypertension | 39 (50.6) | 17 (41.5) | 22 (61.1) | 0.09 |
| Type 2 diabetes mellitus | 29 (37.6) | 14 (34.1) | 15 (41.7) | 0.50 |
| Coronary artery disease | 12 (15.6) | 7 (17.1) | 5 (13.9) | 0.70 |
| Child–Pugh score | ||||
| A | 51 (66.2) | 34 (82.9) | 26 (72.2) | 0.06 |
| B (≤B7) | 15 (19.5) | 7 (17.1) | 10 (27.8) | 0.06 |
| BCLC staging system | ||||
| Stage A | 5 (6.5) | 3 (7.3) | 2 (5.6) | 0.75 |
| Stage B | 30 (39) | 14 (34.1) | 16 (44.4) | 0.36 |
| Stage C | 42 (54.5) | 24 (58.5) | 18 (50) | 0.45 |
| HCC characteristics | ||||
| Tumor size (cm) | 5.8 (4.3–8.9) | 6.7 (4.7–9) | 5 (3.7–6.7) | 0.13 |
| <5 | 31 (40.3) | 14 (34.1) | 17 (47.2) | 0.24 |
| ≥5 | 46 (59.7) | 27 (65.9) | 19 (52.8) | 0.24 |
| Uninodular | 36 (46.8) | 21 (51.2) | 15 (41.7) | 0.40 |
| Multinodular (2–5 nodules) | 5 (6.5) | 1 (2.4) | 4 (11.1) | 0.12 |
| Diffuse (>5 nodules) | 36 (46.8) | 19 (46.3) | 17 (47.2) | 0.94 |
| PVI | 33 (42.9) | 19 (46.3) | 14 (38.9) | 0.51 |
| Serum AFP level (kUI/L) | 19 (6–432) | 56 (7–2,442) | 10 (4–62) | 0.49 |
| Ascites | 8 (10.4) | 4 (9.8) | 4 (11.1) | 0.85 |
| Cirrhosis | 66 (85.7) | 36 (87.8) | 30 (83.3) | 0.58 |
| Chronic alcoholism | 35 (45.5) | 17 (41.5) | 18 (50) | 0.45 |
| Viral infection type B | 8 (10.4) | 5 (12.2) | 3 (8.3) | 0.58 |
| Viral infection type C | 19 (24.7) | 12 (29.3) | 7 (19.4) | 0.32 |
| Hemochromatosis | 3 (3.9) | 2 (4.9) | 1 (2.8) | 0.64 |
| NASH | 8 (10.4) | 4 (9.8) | 4 (11.1) | 0.85 |
| Extrahepatic metastasis | 5 (6.5) | 3 (7.3) | 2 (5.6) | 0.75 |
NASH = nonalcooholic steatohepatitis.
Values are median, with 25th–75th interquartile range in parentheses, or n, with percentages in parentheses.